A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) N. Colombo et al.   ANNALS OF ONCOLOGY

Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer

(2013) Marcos Ballester et al.   GYNECOLOGIC ONCOLOGY

Association between tumor diameter and lymphovascular space invasion among women with early-stage endometrial cancer

(2013) Joel Laufer et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Comparison of Diagnostic Accuracy of Frozen Section with Imprint Cytology for Intraoperative Examination of Sentinel Lymph Node in Early-Stage Endometrial Cancer: Results of Senti-Endo Study

(2012) Marcos Ballester et al.   ANNALS OF SURGICAL ONCOLOGY

Patterns of Recurrence in Stage I Endometrioid Endometrial Adenocarcinoma With Lymphovascular Space Invasion

(2012) Fiona Simpkins et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer

(2011) Saketh R. Guntupalli et al.   GYNECOLOGIC ONCOLOGY

Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma?

(2011) E.K. Nugent et al.   GYNECOLOGIC ONCOLOGY

Clinical Practice Guidelines for the Management of Patients With Endometrial Cancer in France

(2011) Denis Querleu et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO)

(2011) Marcos Ballester et al.   LANCET ONCOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

(2010) RA Nout et al.   LANCET

Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality

(2009) DJ O’Brien et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

(2009) Sergio Pecorelli   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial

(2008) P. B. Panici et al.   JNCI-Journal of the National Cancer Institute

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

(2008)   LANCET